Unlocking an Affordable Future: Key #1 Ensure System Sustainability ENSURE SYSTEM SUSTAINABILITY BY PROMOTING COMPETITION A competitive private market is the best way to manage drug costs. Interventions should be focused on fixing specific market failures or gaps rather than
If Drug Companies Had Their Way… There Would Be No Check on Their Power Download Infographic Patients Would Pay List Price for Drugs Drug companies often raise list prices annually in January and July. In January 2021, 822 brand drugs
Smoke and Mirrors Don’t let big drug companies’ smoke and mirrors fool you: High drug costs start and end with them. While pharmacy benefit companies are lowering costs, drug companies are busy blaming everyone in the supply chain but themselves
In case you missed it, former U.S. Representative for Pennsylvania’s 6th Congressional District Ryan Costello discusses how recent legislation targeting pharmacy benefit companies will raise costs for taxpayers and patients and do nothing to address the root cause of high
Pharmacy Benefit Companies Negotiate with Big Drug Companies to Lower Prescription Drug Costs for Patients and Families Last week, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing, “The Need to Make Insulin Affordable for All Americans,”
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is releasing new research showing that premiums would rise by over 50 percent if Medicare Part D plans are prohibited from negotiating rebates on brand drugs. Manufacturers have chosen to negotiate price concessions with PBMs
In 2018, more than 44 million seniors and people with disabilities are expected to be enrolled in Medicare Part D. The national average premium in 2018 is $35.02, only $2.60 higher than the national average premium in 2014 (representing less
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
Health care, business, political, and economic experts all agree pharmacy benefit companies deliver significant savings and play a critical role mitigating costs and supporting access to affordable, quality prescription drug coverage for employers and patients. A number of economists, academics,
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement today ahead of the U.S. House Committee on Oversight and Accountability hearing titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets
©2024 PCMA. All Rights Reserved.
